GLP-1 drug market is experiencing explosive growth, with a current value of US$20.43 billion and a projected CAGR of 25.7% to reach US$99.94 billion by 2029. This surge is driven by several factors, including the increasing prevalence of diabetes and obesity, the effectiveness of GLP-1 drugs in controlling these conditions, and their potential application in treating other diseases like...